PharmaCyte Biotech to Attend 15th International Conference on Advanced Technologies and Treatments for Diabetes
LAS VEGAS–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that the management team will be attending the 15th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) held April 27-30, 2022, in Barcelona, Spain.
Read more →